Your Location：
Home >
Browse articles >
Chinese Medicines Regulate p38 MAPK， ERK1/2， and JNK in Treatment of Osteoporosis： A Review
Chinese Medicines Regulate p38 MAPK， ERK1/2， and JNK in Treatment of Osteoporosis： A Review
Enhanced Publication- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 12, Pages: 222-229(2023)
DOI： 10.13422/j.cnki.syfjx.20230343
Scan QR Code
Full Text(HTML)
References
Publication Info
Metrics
171
Views
86
Downloads
10
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Role of p38 MAPK Pathway in Diabetic Peripheral Neuropathy and Chinese Medicine Intervention： A Review
Interventional Effect of Active Ingredients of Chinese Medicine and Compound Formulas on Epithelial-mesenchymal Transition in Lung Cancer： A Review
Mechanism of Chinese Medicine in Promoting Angiogenesis After Ischemic Stroke Based on PI3K/Akt Signaling Pathway： A Review
Anti-osteoporosis Effect of Isorhamnetin： A Review
Traditional Chinese Medicine Intervention in Depression Based on Signaling Pathway Regulation： A Review
Related Author
YANG Peng
ZHANG Chengfei
ZHANG Yaqi
PENG Chuan
ZHANG Qiue
WU Lili
QIN Lingling
LIU Tonghua
Related Institution
The First Clinical School of Medicine， Shaanxi University of Chinese Medicine
Key Laboratory of Traditional Chinese Medicine （TCM） and Health Sciences， Ministry of Education， Beijing University of Chinese Medicine
Dongzhimen Hospital， Beijing University of Chinese Medicine
Chengdu University of TCM
Beijing Shijitan Hospital， Capital Medical University
Chat
